image

The best stocks to buy since 1993

Latest issue now available

Tarsus

July 2009

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TRS
  • Price:
  • 96p
Very odd acquisition for Tarsus, which is buying tiny AIM listed CapRegen. Of CapRegen's directors there is only one who is independent of Tarsus and it therefore looks like a deal done to save directors’ blushes.In 2006, Tarsus acquired 80% of MCII, which runs a number of anti-ageing conferences in the US and CapRegen was established and floated on AIM in order to make investments in anti-ageing healthcare products and technologies. The business plan hasn't gone as expected and despite three small investments CapRegen still has £3.44m uninvested cash. Tarsus is offering 1 new share for 24 Capregen shares, which values Capregen at £3.7m based on a Tarsus share price of 100p. Tarsus already holds 15.5m Capregen shares so ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe